Sarepta Therapeutics, Inc.·4

Mar 11, 8:00 PM ET

Connelly Deirdre P 4

4 · Sarepta Therapeutics, Inc. · Filed Mar 11, 2025

Insider Transaction Report

Form 4
Period: 2025-03-10
Transactions
  • Award

    Common Stock

    2025-03-10+2,3835,225 total
  • Award

    Stock Options (right to buy)

    2025-03-10+4,7924,792 total
    Exercise: $99.69From: 2026-03-10Exp: 2035-03-10Common Stock (4,792 underlying)
Footnotes (1)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4